BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 24705136)

  • 1. Zebrafish models of human motor neuron diseases: advantages and limitations.
    Babin PJ; Goizet C; Raldúa D
    Prog Neurobiol; 2014 Jul; 118():36-58. PubMed ID: 24705136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary spastic paraplegia: More than an upper motor neuron disease.
    Parodi L; Fenu S; Stevanin G; Durr A
    Rev Neurol (Paris); 2017 May; 173(5):352-360. PubMed ID: 28449883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fishing for causes and cures of motor neuron disorders.
    Patten SA; Armstrong GA; Lissouba A; Kabashi E; Parker JA; Drapeau P
    Dis Model Mech; 2014 Jul; 7(7):799-809. PubMed ID: 24973750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic architecture of motor neuron diseases.
    Chaudhary R; Agarwal V; Rehman M; Kaushik AS; Mishra V
    J Neurol Sci; 2022 Mar; 434():120099. PubMed ID: 34965490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Spinal Muscular Atrophy in Zebrafish: Current Advances and Future Perspectives.
    Gonzalez D; Vásquez-Doorman C; Luna A; Allende ML
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.
    Jaiswal MK
    Neural Regen Res; 2017 May; 12(5):723-736. PubMed ID: 28616022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss.
    Kobayashi Z; Tsuchiya K; Arai T; Yokota O; Yoshida M; Shimomura Y; Kondo H; Haga C; Asaoka T; Onaya M; Ishizu H; Akiyama H; Mizusawa H
    J Neurol Sci; 2010 Nov; 298(1-2):70-7. PubMed ID: 20810131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development.
    Faravelli I; Frattini E; Ramirez A; Stuppia G; Nizzardo M; Corti S
    J Clin Med; 2014 Oct; 3(4):1124-45. PubMed ID: 26237595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for motor neuron disease.
    Green SL; Tolwani RJ
    Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor unit firing in amyotrophic lateral sclerosis and other upper and lower motor neurone disorders.
    de Carvalho M; Turkman A; Swash M
    Clin Neurophysiol; 2012 Nov; 123(11):2312-8. PubMed ID: 22627021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA dysregulation in diseases of motor neurons.
    Ibrahim F; Nakaya T; Mourelatos Z
    Annu Rev Pathol; 2012; 7():323-52. PubMed ID: 22035195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis.
    Körner S; Kollewe K; Fahlbusch M; Zapf A; Dengler R; Krampfl K; Petri S
    Muscle Nerve; 2011 May; 43(5):636-42. PubMed ID: 21484822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
    Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes.
    Gilbert RM; Fahn S; Mitsumoto H; Rowland LP
    Mov Disord; 2010 Sep; 25(12):1868-75. PubMed ID: 20669307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical motor neuron disease and related motor syndromes.
    Verma A; Bradley WG
    Semin Neurol; 2001 Jun; 21(2):177-87. PubMed ID: 11442326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
    Hadano S; Kunita R; Otomo A; Suzuki-Utsunomiya K; Ikeda JE
    Neurochem Int; 2007; 51(2-4):74-84. PubMed ID: 17566607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.
    Dentel C; Palamiuc L; Henriques A; Lannes B; Spreux-Varoquaux O; Gutknecht L; René F; Echaniz-Laguna A; Gonzalez de Aguilar JL; Lesch KP; Meininger V; Loeffler JP; Dupuis L
    Brain; 2013 Feb; 136(Pt 2):483-93. PubMed ID: 23114367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP-43 pathology.
    Genç B; Gautam M; Gözütok Ö; Dervishi I; Sanchez S; Goshu GM; Koçak N; Xie E; Silverman RB; Özdinler PH
    Clin Transl Med; 2021 Feb; 11(2):e336. PubMed ID: 33634973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.